MACK-CALI REALTY CORP (CLI)

REIT

18.35  -0.04 (-0.22%)

After market: 18.35 0 (0%)

Fundamental Rating

1

Taking everything into account, CLI scores 1 out of 10 in our fundamental rating. CLI was compared to 126 industry peers in the Diversified REITs industry. CLI has a bad profitability rating. Also its financial health evaluation is rather negative. CLI does not seem to be growing, but still is valued expensively.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

CLI had negative earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -0.6%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 1.69%
PM (TTM) -8.44%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

0

2. Health

2.1 Basic Checks

CLI has about the same amout of shares outstanding than it did 1 year ago.
CLI has a worse debt/assets ratio than last year.

2.2 Solvency

CLI has a Debt/Equity ratio of 1.82. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.82
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

2

3. Growth

3.1 Past

CLI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 81.65%, which is quite impressive.
CLI shows a decrease in Revenue. In the last year, the revenue decreased by -1.41%.
The Revenue for CLI have been decreasing by -12.02% on average. This is quite bad
EPS 1Y (TTM)81.65%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-450%
Revenue 1Y (TTM)-1.41%
Revenue growth 3Y-11.92%
Revenue growth 5Y-12.02%
Revenue growth Q2Q7.78%

3.2 Future

Based on estimates for the next years, CLI will show a small growth in Earnings Per Share. The EPS will grow by 0.95% on average per year.
Based on estimates for the next years, CLI will show a small growth in Revenue. The Revenue will grow by 4.79% on average per year.
EPS Next Y-65.7%
EPS Next 2Y7.87%
EPS Next 3Y16.13%
EPS Next 5Y0.95%
Revenue Next Year-3.9%
Revenue Next 2Y-1.99%
Revenue Next 3Y3.38%
Revenue Next 5Y4.79%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLI. In the last year negative earnings were reported.
Also next year CLI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 34.15

4.3 Compensation for Growth

CLI's earnings are expected to grow with 16.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.87%
EPS Next 3Y16.13%

More info and screens

3

5. Dividend

5.1 Amount

CLI has a Yearly Dividend Yield of 3.24%.
Compared to an average S&P500 Dividend Yield of 2.43, CLI pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.24%

5.2 History

The dividend of CLI decreases each year by -5.01%.
CLI has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-5.01%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

CLI pays out 69.62% of its income as dividend. This is not a sustainable payout ratio.
DP69.62%
EPS Next 2Y7.87%
EPS Next 3Y16.13%

More info and screens

MACK-CALI REALTY CORP

NYSE:CLI (12/9/2021, 7:16:41 PM)

After market: 18.35 0 (0%)

18.35

-0.04 (-0.22%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.67B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 3.24%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.6%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 1.69%
PM (TTM) -8.44%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 1.82
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)81.65%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-65.7%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.41%
Revenue growth 3Y-11.92%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y